1. Clinical Overview
Tolperisone is a centrally acting muscle relaxant used primarily for the treatment of spasticity associated with neurological and musculoskeletal conditions. It acts by blocking voltage-gated sodium and calcium channels, leading to a reduction in excessive muscle tone without significant sedation. The 450mg strength is a commonly prescribed high-dose formulation in India for managing moderate to severe spasticity.
| Onset | Duration | Bioavailability |
|---|---|---|
| Approximately 30 to 60 minutes after oral administration. | Approximately 4 to 6 hours. | Approximately 20% due to significant first-pass metabolism. |
2. Mechanism of Action
Tolperisone exerts its muscle relaxant effect through multiple mechanisms. Its primary action is the blockade of voltage-gated sodium channels in the membranes of neurons, which stabilizes hyperexcited nerve cells and reduces the frequency of action potentials. This leads to a decrease in the excessive reflex activity of alpha and gamma motor neurons in the spinal cord. Additionally, it blocks L-type voltage-gated calcium channels and enhances the activity of potassium channels, contributing to membrane stabilization and reduced muscle tone.
3. Indications & Uses
- Symptomatic treatment of spasticity associated with neurological conditions (e.g., multiple sclerosis, stroke, cerebral palsy, spinal cord injuries)
- Muscle spasm associated with painful musculoskeletal conditions (e.g., cervical syndrome, low back pain, lumbar syndrome)
4. Dosage & Administration
Adult Dosage: 150mg to 450mg per day, divided into 2-3 doses. The usual recommended dose is 150mg three times daily (450mg total). Initiate at lower dose (e.g., 150mg twice daily) and titrate based on response and tolerance.
Administration: Tablet should be swallowed whole with a sufficient amount of water, preferably after meals to minimize gastrointestinal discomfort. Do not crush or chew. The daily dose should be divided and taken at regular intervals.
5. Side Effects
Common side effects may include:
- Nausea
- Abdominal discomfort/pain
- Dyspepsia
- Headache
- Dizziness
- Fatigue
- Dry mouth
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| CYP2D6 Inhibitors (e.g., Fluoxetine, Paroxetine, Quinidine) | Increased plasma concentration of tolperisone, leading to enhanced effects and risk of toxicity. | Major |
| CYP3A4 Inhibitors (e.g., Ketoconazole, Clarithromycin, Verapamil) | Increased tolperisone exposure, increasing risk of adverse effects. | Moderate |
| Other CNS Depressants (e.g., Alcohol, Benzodiazepines, Opioids, Sedating Antihistamines) | Additive sedative effects, increased risk of dizziness, drowsiness, and impaired motor skills. | Major |
| Antihypertensives (e.g., Beta-blockers, ACE inhibitors, Diuretics) | Potentiation of hypotensive effect, risk of orthostatic hypotension. | Moderate |
| Anticholinergic drugs (e.g., Atropine, Tricyclic Antidepressants) | Additive anticholinergic side effects (dry mouth, constipation, urinary retention). | Moderate |
7. Patient Counselling
- Do take the tablet after meals with water.
- Do not crush, chew, or break the tablet.
- Do not suddenly stop the medication without consulting your doctor.
- Do not take a double dose to make up for a missed one.
- Do inform all your doctors about all medications you are taking.
8. Toxicology & Storage
Overdose: Symptoms may include severe CNS depression (drowsiness, coma), cardiovascular collapse (severe hypotension, bradycardia), respiratory depression, nausea, vomiting, and muscle weakness. Seizures have been reported in severe cases.
Storage: Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.